Catheter ablation vs optimized medical care for very elderly with atrial fibrillation
Official title: Assessment of the Effect of Catheter Ablation on Elderly Population With Atrial Fibrillation; a Randomized Controlled Study; The ACE-AF Study
Run by Karolinska University Hospital · NCT07424690 · Data updated 2026-11-12
In people aged 78 and up with AF, this study tests whether catheter ablation can help by comparing it to tailored medical therapy, using a wearable rhythm monitor to track AF over time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 78 Years and up |
| Sex | All |
| Enrollment | 282 (estimated) |
| Sponsor | Karolinska University Hospital Academic / other |
| Locations | 2 sites (Linköping and 1 other locations) |
| Status | Recruiting |
| Started | October 5, 2026 |
| Main results expected | December 15, 2031 |
| Study ends | September 15, 2034 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07424690 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 78 years or older with symptomatic AF, suitable for ablation, and with acceptable comorbidity (Charlson index ≤7).
✕Probably not a fit
Patients with high operative risk, significant left atrial enlargement, recent major cardiac events, or contraindications to anticoagulation may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
ACE-AF is a multicenter randomized trial evaluating catheter ablation against optimized medical therapy in adults 78 years and older with symptomatic AF. Participants are assigned 1:1 to ablation with standard rhythm-control strategies or to optimized medical therapy without ablation, with an implantable loop recorder continuously measuring AF burden. The trial uses contemporary ablation practices, prioritizing pulmonary vein isolation, and allows AV node ablation with pacemaker if clinically indicated. Randomization is stratified by sex and age group, and outcomes focus on rhythm and clinical endpoints while monitoring safety in an older population.
Why it matters
Potential benefit: If successful, the ablation strategy could offer better rhythm control and quality of life for very elderly patients with AF.
How similar studies have gone: Prior trials of AF ablation in older adults are limited; this pragmatic, randomized design with continuous rhythm monitoring is innovative in this age group.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥78 years. 2. ECG-documented atrial fibrillation. 3. AF type: paroxysmal, persistent, or longstanding persistent AF. 4. Suitable candidate for catheter ablation according to ESC guidelines. 5. Charlson's comorbidity index ≤7. Exclusion Criteria: 1. Left atrial (LA) dimension \>55 mm, based on echocardiography within the previous year. 2. Acute coronary syndrome or coronary artery bypass surgery within the last 12 weeks. 3. Severe valvular heart disease (per ESC definitions) or congenital heart disease. 4. Prior surgical or catheter AF ablation procedure, or prior AV-node (atrioventricular nodal) ablation. 5. Contraindication to oral anticoagulation. 6. AF due to a reversible cause. 7. Medical condition likely to limit survival to \<12 months. 8. Unable or unwilling to provide informed consent. 9. History of non-compliance with medical therapy. 10. BMI \<18 or \>37 kg/m².
Where it's running
-
Karolinska University Hospital
Stockholm, Sweden Recruiting -
Linköping University Hospital
Linköping, Sweden Not yet recruiting
Study contacts
- Principal investigator: Emmanouil Charitakis, MD, PhD — Karolinska University Hospital
- Study coordinator: Emmanouil Charitakis, MD, PhD
- Email: emmanouil.charitakis@regionstockholm.se
- Phone: 0046767877506
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BDNF Levels and Atrial Cardiomyopathy in People Having AF Ablation
This study tests whether circulating BDNF levels are linked to atrial cardiomyopathy in adults having their first ablation for persistent atrial fibrillation.
-
Pulsed Field Ablation Outcomes in Atrial Fibrillation: Randomized Comparison to Traditional Ablation
This study tests pulsed field ablation versus conventional radiofrequency ablation in adults with atrial fibrillation to see which method better preserves heart rhythm.
-
Comparing FARAPULSE and FARAWAVE Nav catheters during pulmonary vein isolation for atrial fibrillation
This test will see if the FARAWAVE Nav catheter's built-in mapping can be used instead of pre-procedure CT scans for adults having pulmonary vein isolation for atrial fibrillation.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.